|
Re: BTD
|
6
|
Resverlogix Corp.
|
Apr 24, 2022 01:58PM
|
|
Re: Market Woes
|
6
|
Resverlogix Corp.
|
Apr 30, 2022 11:23AM
|
|
Re: A couple of things
|
9
|
Resverlogix Corp.
|
May 03, 2022 01:38AM
|
|
Re: A couple of things
|
5
|
Resverlogix Corp.
|
May 03, 2022 12:12PM
|
|
Re: A couple of things
|
1
|
Resverlogix Corp.
|
May 03, 2022 12:30PM
|
|
Re: A couple of things
|
2
|
Resverlogix Corp.
|
May 03, 2022 01:28PM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
10
|
Resverlogix Corp.
|
May 09, 2022 10:46AM
|
|
Re: RVX ANNOUNCES TYPE C MEETING WITH FDA FOR CORAL, A PHASE 3 HIGH-RISK COVID-19 OUTPATIENT STUDY
|
6
|
Resverlogix Corp.
|
May 09, 2022 01:10PM
|
|
Re: US Covid #'s
|
4
|
Resverlogix Corp.
|
May 09, 2022 02:24PM
|
|
Re: New name.
|
7
|
Resverlogix Corp.
|
May 10, 2022 10:03PM
|
|
Re: AGM June 21
|
5
|
Resverlogix Corp.
|
May 13, 2022 03:21PM
|
|
Re: Zenith Epigenetics Announces Initiation of a Phase 2b Triple Negative Breast Cancer (TNBC) Clinical Trial
|
6
|
Zenith Epigenetics
|
May 14, 2022 01:15PM
|
|
Re: Q1- March 31, 2022 on SEDAR
|
7
|
Resverlogix Corp.
|
May 14, 2022 10:05PM
|
|
Re: great,good,bad,ugly or so so??
|
7
|
Resverlogix Corp.
|
May 18, 2022 03:32PM
|
|
Compensation
|
6
|
Resverlogix Corp.
|
May 21, 2022 01:13PM
|
|
AGM attendance
|
6
|
Resverlogix Corp.
|
May 21, 2022 01:38PM
|
|
Re: Compensation
|
2
|
Resverlogix Corp.
|
May 21, 2022 01:39PM
|
|
Re: AGM attendance
|
5
|
Resverlogix Corp.
|
May 25, 2022 03:30PM
|
|
Re: Level 2 Quotes this morning
|
7
|
Resverlogix Corp.
|
Jun 16, 2022 02:23PM
|
|
Re: A couple of things
|
6
|
Resverlogix Corp.
|
Jun 17, 2022 12:05AM
|
